Paraxanthine
Enfinity® Paraxanthine
Paraxanthine has been becoming increasingly popular as a new and cutting-edge ingredient in the world of sports and cognitive performance supplements as well as a replacement for traditional caffeine. Paraxanthine is one of the primary metabolites of caffeine but can offer some additional unique benefits. Paraxanthine can contribute many of the stimulating effects associated with caffeine but with a more targeted and potentially more efficient profile. This makes paraxanthine an attractive option for individuals seeking the benefits of caffeine—such as increased energy, focus, alertness, and reaction time—without some of the common downsides like jitters or crashes after consumption. Let’s look at some of these unique benefits and what paraxanthine can do for you as an addition to your regimen.
One of the primary benefits of paraxanthine is its ability to enhance mental clarity and focus. This compound has been shown to improve cognitive function by increasing dopamine levels and reducing adenosine, which are key factors in promoting alertness and reducing fatigue. By doing so, paraxanthine can help individuals maintain sharp mental focus during demanding tasks, whether it’s an intense workout, a long day at the office, or any other event that might require heightened alertness. Unlike caffeine, which can sometimes cause overstimulation and anxiety, paraxanthine appears to provide a smoother, more sustained boost in mental energy, making it ideal for prolonged periods of concentration.
In addition to its cognitive benefits, paraxanthine can also support certain areas of physical performance. Studies suggest that paraxanthine can increase fatty acid mobilization, which allows them to then be used energy production. This can lead to improvements in endurance and reduce perceived exertion during exercise. When this happens effectively, athletes and other users may experience less fatigue and greater stamina during their workouts, allowing them to train harder and longer. Paraxanthine's ability to enhance energy metabolism without significantly increasing heart rate or blood pressure outside of what would be expected also can make it a safer and more focused stimulant for physical performance.
Another important advantage of paraxanthine is its potential to reduce some of the negative side effects commonly associated with caffeine consumption/overconsumption. While caffeine can sometimes cause sleep disturbances when taken close to sleep or lead to a post-stimulation energy crash, paraxanthine is metabolized more efficiently, potentially leading to fewer issues with sleeplessness or energy dips.
It’s also important to note that currently paraxanthine shows that there are no non-responders to paraxanthine. As opposed to traditional caffeine, its metabolism and effects can vary from person to person. In fact, there are fast, medium, and slow metabolizers of caffeine. From person to person, this can mean that caffeine’s half-life can vary anywhere from 1.5-10.5 hours. However, some research has shown that caffeine clearance can vary as much as 40x between consumers. What anecdotal evidence shows when all these individuals ingest paraxanthine, is that it leads to a much smoother and consistent experience for everyone. Paraxanthine has a much shorter half-life when compared to caffeine, meaning it can exit the body more quickly and reduce the likelihood of lingering effects that can interfere with rest and recovery. At 3.1 hours, it’s less than half of the half-life, which leads to caffeine’s general half-life being around 4.1 hours. T
Paraxanthine represents a promising new alternative to traditional caffeine-based stimulants. By offering similar cognitive and physical performance benefits with fewer side effects, paraxanthine is quickly becoming a popular choice for those looking to optimize their energy levels, focus, physical performance, and quality of life. Whether you're an athlete aiming to push your limits in the gym or someone needing a mental boost to power through busy tasks, paraxanthine can provide an efficient and effective solution for mental clarity and enhanced performance.
REFERENCES
Hetzler, R. K., et al. “Effect of Paraxanthine on FFA Mobilization after Intravenous Caffeine Administration in Humans.” Journal of Applied Physiology (Bethesda, Md.: 1985), vol. 68, no. 1, 1 Jan. 1990, pp. 44–47, pubmed.ncbi.nlm.nih.gov/2312486/, doi:10.1152/jappl.1990.68.1.44; https://pubmed.ncbi.nlm.nih.gov/2312486/
Benowitz, Neal L., et al. “Sympathomimetic Effects of Paraxanthine and Caffeine in Humans*.” Clinical Pharmacology & Therapeutics, vol. 58, no. 6, Dec. 1995, pp. 684–691, doi:10.1016/0009-9236(95)90025-x; https://pubmed.ncbi.nlm.nih.gov/8529334/
Bromberg-Martin, Ethan S et al. “Dopamine in motivational control: rewarding, aversive, and alerting.” Neuron vol. 68,5 (2010): 815-34. doi:10.1016/j.neuron.2010.11.022; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032992/
Wardle, Margaret C et al. “Caffeine increases psychomotor performance on the effort expenditure for rewards task.” Pharmacology, biochemistry, and behavior vol. 102,4 (2012): 526-31. doi:10.1016/j.pbb.2012.06.016; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578395/
Orrú, Marco, et al. “Psychostimulant Pharmacological Profile of Paraxanthine, the Main Metabolite of Caffeine in Humans.” Neuropharmacology, vol. 67C, 1 Apr. 2013, pp. 476–484, doi:10.1016/j.neuropharm.2012.11.029; https://www.sciencedirect.com/science/article/abs/pii/S002839081200576X
Guerreiro, Serge, et al. “Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels.” Molecular Pharmacology, vol. 74, no. 4, 11 July 2008, pp. 980–989, doi:10.1124/mol.108.048207; https://pubmed.ncbi.nlm.nih.gov/18621927/
Ren, Xiangpeng, and Jiang-Fan Chen. “Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms.” Frontiers in neuroscience vol. 14 602697. 17 Dec. 2020, doi:10.3389/fnins.2020.602697; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773776/
Orrú, Marco et al. “Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.” Neuropharmacology vol. 67 (2013): 476-84. doi:10.1016/j.neuropharm.2012.11.029; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562388/
Nehlig, Astrid. “Is Caffeine a Cognitive Enhancer?” Journal of Alzheimer’s Disease, vol. 20, no. s1, 14 Apr. 2010, pp. S85–S94, pubmed.ncbi.nlm.nih.gov/20182035/, doi:10.3233/jad-2010-091315; https://pubmed.ncbi.nlm.nih.gov/20182035/
Yoo, Choongsung et al. “Acute Paraxanthine Ingestion Improves Cognition and Short-Term Memory and Helps Sustain Attention in a Double-Blind, Placebo-Controlled, Crossover Trial.” Nutrients vol. 13,11 3980. 9 Nov. 2021, doi:10.3390/nu13113980; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622427/
Wadhawan, Manav, and Anil C. Anand. “Coffee and Liver Disease.” Journal of Clinical and Experimental Hepatology, vol. 6, no. 1, 1 Mar. 2016, pp. 40–46, doi:10.1016/j.jceh.2016.02.003; https://pubmed.ncbi.nlm.nih.gov/27194895/
Heath, Ryan D, et al. “Coffee: The Magical Bean for Liver Diseases.” World Journal of Hepatology, vol. 9, no. 15, 28 May 2017, pp. 689–696, doi:10.4254/wjh.v9.i15.689; https://pubmed.ncbi.nlm.nih.gov/28596816/
Gressner, Olav A., et al. “Identification of Paraxanthine as the Most Potent Caffeine-Derived Inhibitor of Connective Tissue Growth Factor Expression in Liver Parenchymal Cells.” Liver International, vol. 29, no. 6, July 2009, pp. 886–897, doi:10.1111/j.1478-3231.2009.01987.x; https://pubmed.ncbi.nlm.nih.gov/19291178/
Volkow, N D et al. “Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.” Translational psychiatry vol. 5,4 e549. 14 Apr. 2015, doi:10.1038/tp.2015.46; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462609/
Solinas, Marcello, et al. “Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens.” The Journal of Neuroscience, vol. 22, no. 15, 1 Aug. 2002, pp. 6321–6324, doi:10.1523/jneurosci.22-15-06321.2002; https://www.jneurosci.org/content/22/15/6321
dePaula, Juliana, and Adriana Farah. “Caffeine Consumption through Coffee: Content in the Beverage, Metabolism, Health Benefits and Risks.” Beverages, vol. 5, no. 2, 1 June 2019, p. 37, doi:10.3390/beverages5020037; https://www.mdpi.com/2306-5710/5/2/37/htm
Guessous, Idris, et al. “Associations of Ambulatory Blood Pressure with Urinary Caffeine and Caffeine Metabolite Excretions.” Hypertension, vol. 65, no. 3, Mar. 2015, pp. 691–696, doi:10.1161/hypertensionaha.114.04512; https://pubmed.ncbi.nlm.nih.gov/25489060/
Stavric, B. “Methylxanthines: Toxicity to Humans. 3. Theobromine, Paraxanthine and the Combined Effects of Methylxanthines.” Food and Chemical Toxicology, vol. 26, no. 8, Jan. 1988, pp. 725–733, doi:10.1016/0278-6915(88)90073-7; https://pubmed.ncbi.nlm.nih.gov/3058562/
Okuro, Masashi et al. “Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice.” Sleep vol. 33,7 (2010): 930-42. doi:10.1093/sleep/33.7.930; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894435/
Barnes, Peter J. “Theophylline”. American Journal of Respiratory and Critical Care Medicine. Volume 188, Issue 8. 03 May 2013. Doi: 10.1164/rccm.201302-0388PP; https://www.atsjournals.org/doi/full/10.1164/rccm.201302-0388PP
Purpura, Martin, et al; “Paraxanthine-based bioactive composition and method of use thereof”. United States Patent and Trademark Office. Patent US20230072854A1. 9 Mar. 2023; https://patents.google.com/patent/WO2021151094A1/
Wittayalertpanya, Supeecha, et al. “Paraxanthine/Caffeine Ratio: As an Index for CYP1A2 Activity in Polycyclic Aromatic Hydrocarbons Exposed Subjects.” Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, vol. 86 Suppl 2, 1 June 2003, pp. S310-317; https://pubmed.ncbi.nlm.nih.gov/12930004/
